Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;44(8):1347-1354.
doi: 10.1007/s00259-017-3643-2. Epub 2017 Feb 11.

Preclinical imaging characteristics and quantification of Platinum-195m SPECT

E A Aalbersberg  1 , B J de Wit-van der Veen  1 , O Zwaagstra  2 , K Codée-van der Schilden  2 , E Vegt  1 , Wouter V Vogel  3
Affiliations

Preclinical imaging characteristics and quantification of Platinum-195m SPECT

E A Aalbersberg et al. Eur J Nucl Med Mol Imaging. 2017 Aug.

Abstract

Aims: In vivo biodistribution imaging of platinum-based compounds may allow better patient selection for treatment with chemo(radio)therapy. Radiolabeling with Platinum-195m (195mPt) allows SPECT imaging, without altering the chemical structure or biological activity of the compound. We have assessed the feasibility of 195mPt SPECT imaging in mice, with the aim to determine the image quality and accuracy of quantification for current preclinical imaging equipment.

Methods: Enriched (>96%) 194Pt was irradiated in the High Flux Reactor (HFR) in Petten, The Netherlands (NRG). A 0.05 M HCl 195mPt-solution with a specific activity of 33 MBq/mg was obtained. Image quality was assessed for the NanoSPECT/CT (Bioscan Inc., Washington DC, USA) and U-SPECT+/CT (MILabs BV, Utrecht, the Netherlands) scanners. A radioactivity-filled rod phantom (rod diameter 0.85-1.7 mm) filled with 1 MBq 195mPt was scanned with different acquisition durations (10-120 min). Four healthy mice were injected intravenously with 3-4 MBq 195mPt. Mouse images were acquired with the NanoSPECT for 120 min at 0, 2, 4, or 24 h after injection. Organs were delineated to quantify 195mPt concentrations. Immediately after scanning, the mice were sacrificed, and the platinum concentration was determined in organs using a gamma counter and graphite furnace - atomic absorption spectroscopy (GF-AAS) as reference standards.

Results: A 30-min acquisition of the phantom provided visually adequate image quality for both scanners. The smallest visible rods were 0.95 mm in diameter on the NanoSPECT and 0.85 mm in diameter on the U-SPECT+. The image quality in mice was visually adequate. Uptake was seen in the kidneys with excretion to the bladder, and in the liver, blood, and intestine. No uptake was seen in the brain. The Spearman correlation between SPECT and gamma counter was 0.92, between SPECT and GF-AAS it was 0.84, and between GF-AAS and gamma counter it was0.97 (all p < 0.0001).

Conclusion: Preclinical 195mPt SPECT is feasible with acceptable tracer doses and acquisition times, and provides good image quality and accurate signal quantification.

Keywords: 195mPt; SPECT; Small animal imaging.

PubMed Disclaimer

References

    1. J Nucl Med. 1974 May;15(5):349-51 - PubMed
    1. Lancet. 2000 Mar 18;355(9208):949-55 - PubMed
    1. Cancer Chemother Pharmacol. 1988;22(3):241-5 - PubMed
    1. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002225 - PubMed
    1. J Nucl Med. 2013 Jan;54(1):83-9 - PubMed

LinkOut - more resources